Jan-Mark Edewaard increased his holdings by a total of 13,471 shares on January 5 and 8 in the medical cannabis company Odi Pharma, where he is CEO and a board member. The total purchase amount is SEK 48,013 at an average price of SEK 3.56 per share.This is stated in Finansinspektionen's insider register.